sf 2197 has been researched along with l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine in 1 studies
| Studies (sf 2197) | Trials (sf 2197) | Recent Studies (post-2010) (sf 2197) | Studies (l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine) | Trials (l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine) | Recent Studies (post-2010) (l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine) |
|---|---|---|---|---|---|
| 6 | 0 | 1 | 10 | 0 | 0 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kurihara, S; Monma, S; Oikawa, T; Shimada, K; Sugimura, Y; Tamaki, K; Tanzawa, K | 1 |
1 other study(ies) available for sf 2197 and l-n-(n-hydroxy-2-isobutylsuccinamoyl)seryl-l-valine
| Article | Year |
|---|---|
Synthesis and structure-activity relationships of gelatinase inhibitors derived from matlystatins.
Topics: Acetylcysteine; Chromatography, High Pressure Liquid; Dipeptides; Fibrosarcoma; Gelatinases; Humans; Magnetic Resonance Spectroscopy; Metalloendopeptidases; Protease Inhibitors; Pyridazines; Structure-Activity Relationship; Substrate Specificity; Succinates; Thermolysin; Tumor Cells, Cultured | 1995 |